Citadel Advisors’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$634K Sell
459,404
-700,387
-60% -$1.06M ﹤0.01% 8717
2025
Q4
$2.31M Sell
1,159,791
-4,884,452
-81% -$7.51M ﹤0.01% 5642
2025
Q3
$9.85M Buy
6,044,243
+5,039,865
+502% +$9.85M 0.01% 3297
2025
Q2
$2.29M Buy
1,004,378
+815,470
+432% +$1.35M ﹤0.01% 5454
2025
Q1
$293K Sell
188,908
-135,094
-42% -$274K ﹤0.01% 9663
2024
Q4
$761K Buy
324,002
+20,994
+7% +$71K ﹤0.01% 7609
2024
Q3
$1.1M Sell
303,008
-222,780
-42% -$888K ﹤0.01% 6685
2024
Q2
$1.83M Sell
525,788
-160,692
-23% -$693K ﹤0.01% 5485
2024
Q1
$4.38M Buy
686,480
+646,715
+1,626% +$4.03M ﹤0.01% 4143
2023
Q4
$256K Buy
+39,765
New +$152K ﹤0.01% 9477
2023
Q3
Sell
-185,815
Closed -$442K 14268
2023
Q2
$442K Sell
185,815
-1,379,531
-88% -$3.27M ﹤0.01% 8207
2023
Q1
$2.88M Sell
1,565,346
-211,753
-12% -$414K ﹤0.01% 4705
2022
Q4
$3.38M Buy
1,777,099
+634,494
+56% +$1.6M ﹤0.01% 4548
2022
Q3
$2.44M Sell
1,142,605
-1,011,052
-47% -$3M ﹤0.01% 5200
2022
Q2
$6.09M Sell
2,153,657
-1,358,856
-39% -$4.14M 0.01% 3443
2022
Q1
$14.6M Buy
3,512,513
+1,814,570
+107% +$7.63M 0.02% 2402
2021
Q4
$8.81M Sell
1,697,943
-704,891
-29% -$4.23M 0.01% 3281
2021
Q3
$15.7M Sell
2,402,834
-359,920
-13% -$2.27M 0.02% 2363
2021
Q2
$18.3M Buy
2,762,754
+2,721,085
+6,530% +$16.9M 0.02% 2187
2021
Q1
$239K Buy
41,669
+22,661
+119% +$168K ﹤0.01% 11337
2020
Q4
$170K Buy
19,008
+5,640
+42% +$60.1K ﹤0.01% 9853
2020
Q3
$156K Sell
13,368
-565,976
-98% -$8.21M ﹤0.01% 8973
2020
Q2
$9.29M Sell
579,344
-2,360
-0.4% -$26.2K 0.01% 2313
2020
Q1
$3.48M Buy
581,704
+570,163
+4,940% +$5.27M 0.01% 3230
2019
Q4
$152K Buy
+11,541
New +$151K ﹤0.01% 8354
2019
Q3
Sell
-71,285
Closed -$1.15M 9143
2019
Q2
$1.15M Buy
+71,285
New +$1.59M ﹤0.01% 5473

Other funds holding AUTL